Document:

Exhibit 10.35

Exhibit 10.35

Deed of Confirmation of Intellectual Property Rights and Confidentiality

Parties

Unilife Medical Solutions Limited ACN 008 071 403 of Level 5, 35 Clarence Street, Sydney in the
State of New South Wales (Unilife)

Unitract Syringe Pty Ltd ACN 101 059 723 of Level 5, 35 Clarence Street, Sydney, in the State of
New South Wales (Unitract)

Craig Stephen Thorley of [residential address omitted]

Joseph Hermes Kaal of [residential address omitted]

(Thorley
and Kaal separately and jointly referred to throughout as the “Inventors’’)

Background

	A	 	The Inventors have previously assigned their rights to and interests in the
Patents to Unitract (Original Transfer).
	 
	B	 	Unitract is a wholly owned subsidiary of Unilife.
	 
	C	 	The Inventors have performed and continue to assist Unilife in the development
of its extensive portfolio of clinical and prefilled safety syringes based on or
using the Patents that are custom designed to meet the injection safety and
functionality requirements of the target healthcare, harm reduction and
pharmaceutical markets, as the case may be.
	 
	D	 	Unilife and Sanofi Winthrop Industrie (SWIND), a company existing and organised
under the laws of France, are currently negotiating (or have already entered
into) various agreements in relation to the evaluation, exclusive access to and
industrialisation of Unilife’s Ready to Fill Syringe safety syringe technology.
	 
	E	 	In order to assist in the successful finalisation of ongoing negotiations
between Unilife and SWIND by ensuring that there are no issues related to the
definitive ownership of the IP now existing, Unilife requires the Inventors and
the Inventors agree to enter into this Deed.
	 
	F	 	This Deed serves to provide additional consideration to the Inventors for the
Original Transfer and acknowledges that the Inventors, as part of the Original
Transfer, agreed to the transfer of all title, interest and rights to any and
all Intellectual Property Rights existing at the time of the Original Transfer
or which may come into existence in the future while in the employ of Unilife.
	 
	G	 	The Inventors agree to enter into this Deed to transfer, now and forevermore,
all title, interest and rights to any and all Intellectual Property Rights now
existing, pursuant to the terms of this Deed.

 

 

 

Operative provisions

	1	 	Issue of Shares by Unilife

	1.1	 	The Company agrees to provide additional consideration for the Original Transfer to each of
the Inventors to be satisfied by the issue of the Shares. The Original Transfer also included
an obligation on the Inventors to transfer all Intellectual
Property Rights in connection with the Patents, the Products and the Services which may
come into existence after the Original Transfer. The Inventors agree to confirm their
Original Transfer and the ongoing obligations in respect of such and to be bound by the
obligations and the representations set out in this Deed.

	1.2	 	The Shares will be issued by Unilife to each of the Inventors (or their nominees as directed
by each of the Inventors) fully paid and free from all encumbrances and together with all
rights attaching to them.

	1.3	 	To the extent that there is any legal or regulatory prohibition or restriction on issuing the
Shares, Unilife shall have no obligation to issue the Shares to the Inventors until such
prohibition or restriction is removed and Unilife has all requisite regulatory and other
approvals to issue the Shares.

	1.4	 	The Inventors also acknowledge that any future Intellectual Property Rights developed while
they are employed by Unilife will vest in and become the sole property of Unilife.

	2	 	Confirmation of Intellectual Property Rights

	2.1	 	The Inventors acknowledge that all Intellectual Property Rights created by the Inventors in
connection with the Patents, the Products and/or the Services and existing as at the date of
the Original Transfer were vested in Unitract. In the event that this has not already
happened, and to the extent that any Intellectual Property Rights in relation to the Patents,
the Products and/or the Services came into existence since the date of the Original Transfer
and are currently vested in the Inventors, the Inventors now assign, transfer and convey to
Unitract all of their existing Intellectual Property Rights in and to:

	 	2.1.1	 	the Patents;
	 
	 	2.1.2	 	the Documentation;
	 
	 	2.1.3	 	any Improvements;
	 
	 	2.1.4	 	the Products;

	 	2.1.5	 	all Intellectual Property Rights arising out of or in connection with
the Services; and

	 	2.1.6	 	any other discoveries, improvements, inventions or copyright works or
subject matter as specified in this Deed or including works reproducing or
incorporating or utilising any of Unilife’s Confidential Information or Intellectual
Property Rights which the Inventors have acquired or received or created in the
course of or in connection with the Products or performing the Services.

	2.2	 	The Inventors also acknowledge that all future Intellectual Property Rights arising in
relation to or out of the Patents, the Products and/or the Services vest in Unitract on and
from creation. In consideration of $1.00 each (the receipt of which is acknowledged), and to
the extent such assignment has not already happened, the Inventors now assign, transfer and
convey to Unitract all of their future Intellectual Property Rights and vest such in Unitract
on creation in and to:

	 	2.2.1	 	the Patents;
	 
	 	2.2.2	 	the Documentation;
	 
	 	2.2.3	 	any Improvements;
	 
	 	2.2.4	 	the Products;

 

2

 

	 	2.2.5	 	all Intellectual Property Rights arising out of or in connection with
the Services; and

	 	2.2.6	 	any other discoveries, improvements, inventions or copyright works or
subject matter as specified in this Deed or including works reproducing or
incorporating or utilising any of Unilife’s Confidential Information or Intellectual
Property Rights which the Inventors have acquired or received or created or will
acquire or receive or create in the course of or in connection with the Products or
performing the Services.

	2.3	 	The Inventors agree to execute all documents and do all acts and things required by Unilife
or Unitract for the purpose of giving effect to clauses 2.1
and 2.2.

	2.4	 	The Inventors consent to the use by Unitract, Unilife and their assigns of works created by
the Inventors in connection with the Products, the Patents and/or the Services whether or not
such use would, but for this clause, infringe the Moral Rights of the Inventors.

	2.5	 	The Inventors must fully and promptly disclose to Unilife all future Intellectual Property
Rights that come about in connection with the Services or otherwise in relation to the
Products, including any Improvements.

	3	 	Warranties and Indemnities
	 
	3.1	 	The Inventors each warrant that:

	 	3.1.1	 	each invention in each Patent is original and not copied from any other
works or material;

	 	3.1.2	 	each Improvement (if any) is and will in the future be original and not
copied from any other works or material;

	 	3.1.3	 	all of the Documentation is and will in the future be original and not
copied from any other works or material;

	 	3.1.4	 	he has not assigned, transferred, licensed, encumbered or otherwise
conveyed any right, title or interest in or to any of the Patents, Improvements or
the Documentation to any person or entity other than to Unitract in accordance with
the prior agreement between the parties;

	 	3.1.5	 	he has no agreement(s), relationships(s) or commitment(s) with or to any
other person or entity which may conflict with performing the Services or any of his
obligations under this Deed;

	 	3.1.6	 	the Patents, Improvements and the Documentation do not infringe any
third party’s Intellectual Property Rights;

	 	3.1.7	 	he agrees to be bound by the provisions of the constitution of Unilife
upon allotment of the Shares;

	 	3.1.8	 	he is not acquiring the Shares for the purpose of selling them or
granting, issuing or transferring interests in, or options over them within 12
months of their date of issue. This confirmation is understood to be a statement by
the Inventors of present intention only but not an undertaking not to sell.

 

3

 

	4	 	Confidential Information

	4.1	 	The Inventors acknowledge that the Confidential Information is valuable to Unilife and
Unitract and the Inventors accept and agree to be bound by the terms
of this clause 4.

	4.2	 	Subject to the terms of this Deed, each of the Inventors must:

	 	4.2.1	 	keep the Confidential Information and any Improvements secret and
preserve their confidential nature;

	 	4.2.2	 	not use the Confidential Information or any Improvements for any purpose
other than performing the Services;

	 	4.2.3	 	not disclose or permit the disclosure of the Confidential Information,
except to the extent that disclosure of the Confidential Information is required by
law or with Unilife’s prior written consent;

	 	4.2.4	 	protect the Confidential Information against unauthorised access, use or
disclosure;

	 	4.2.5	 	immediately notify Unilife of any unauthorised access to, use or
disclosure of the Confidential Information or any Improvement; and

	 	4.2.6	 	comply with any reasonable direction from Unilife in relation to the
protection of the Confidential Information or the Improvements.

	4.3	 	The Inventors acknowledge that:

	 	4.3.1	 	the Confidential Information remains and is the property of Unilife or
Unitract (as the case may be) at all times; and

	 	4.3.2	 	this Deed does not convey to the Inventors any proprietary or other
interest in the Confidential Information including but not limited to any
Intellectual Property Rights in the Confidential Information, the Patents, and/or
the Documentation.

	4.4	 	At the request of Unilife, or at the completion of the Services (whichever occurs earlier),
the Inventors must immediately deliver up to Unilife all documents and other media containing
the Confidential Information (or any part thereof) and the Documentation in their possession,
power or control.
	 
	5	 	Release

	5.1	 	The Inventors release each of Unilife and Unitract and their assigns from all Claims which
they may have (whether before or after the date of this Deed) in respect of or in relation to
the use of the Patents, Improvements and/or Documentation by Unilife, Unitract or their
assigns or licensees and/or the production and sale of the Products by Unilife, Unitract or
their assigns or licensees.

	5.2	 	The Inventors acknowledge and agree that the release provided
in clause 5.1 of this Deed may be
pleaded as a bar to any action, suit or proceeding commenced now or taken at any time by any
of the Inventors against Unilife or its assigns or licensees or their officers or employees
with respect to or in relation to the matters referred to in clause
5.1.

 

4

 

	6	 	Restraint Period

Each of the Inventors agree that he will not develop any retractable safety syringe or related
product for any person or entity (other than as requested by Unilife) for a period of five (5)
years after the date of the last of the Services to be performed by the Inventors and, without
limiting this clause 6, acknowledge and agree that all rights and title to and interest in
(including the Intellectual Property Rights in and to) any discoveries, improvements, inventions,
copyright works or subject matter created in breach of or arising from any actions in breach of
this clause 6 will vest in Unitract on creation.

	7	 	Notices

Notices under this Deed may be delivered by hand, by mail or by facsimile to the address set out
above or such other address as notified by a party in writing.

	8	 	Miscellaneous

	8.1	 	A party may not assign any of its rights or obligations under this Deed without the prior
written consent of the other party.

	8.2	 	This Deed is governed by the law of New South Wales. The parties submit to the non-exclusive
jurisdiction of its courts and courts of appeal from them. The parties will not object to the
exercise of jurisdiction by those courts on any basis.

	8.3	 	No variation of this Deed will be of any force or effect unless it is in writing and signed
by the parties to this deed.

	8.4	 	The fact that a party fails to do, or delays in doing, something the party is entitled to do
under this Deed, does not amount to a waiver of any obligation of, or breach of obligation by,
another party. A waiver by a party is only effective if it is in writing. A written waiver
by a party is only effective in relation to the particular obligation or breach in respect of
which it is given. It is not to be taken as an implied waiver of any other obligation or
breach or as an implied waiver of that obligation or breach in relation to any other occasion.

	9	 	Definitions and interpretation
	 
	9.1	 	In this Deed the following definitions apply:

Claims means any claims including actions, suits, causes of action, arbitrations, monies,
debts, dues, costs, demands, verdicts and judgments either at law or in equity or arising
under the provisions of any statute.

Confidential Information means all information provided by Unilife or Unitract to any of
the Inventors or otherwise obtained or created by the Inventors, whether obtained before
or after execution of this Deed, in connection with the Services, the Products, the
Patents, any Improvements or the Documentation in any way relating to Unilife or
Unitract, their business, products, customers, suppliers, contractors or employees
whether furnished in writing, orally or in physical configuration including, without
limitation, the Documentation and all technical data, know-how, concepts, specifications
and diagrams, technical drawings, designs, unpublished information regarding products,
services and proposed products and services and prototypes and includes, but does not
include any information that:

	 	(a)	 	was, and can be demonstrated to have been, known to the Inventors prior
to its communication by Unilife or Unitract;

	 	(b)	 	is or comes into the public domain otherwise than through any default of
the Inventors or through any disclosure by any person acquiring the same from
Unilife or Unitract;

	 	(c)	 	is disclosed to the Inventors by a third party having no obligations of
confidence to the Inventors in respect thereof, and has not been disclosed to that
third party in consequence of a breach of confidence; or

	 	(d)	 	is developed independently by the Inventors otherwise than as part of the
Services and without reference to information disclosed by Unilife or Unitract.

 

5

 

Documentation means such existing or future written manuals or information relevant to
the Products, Patents, Improvements and/or Services as may be created
from time to time by the Inventors including users’ manuals, modification manuals, flow
charts, drawings and listings which are designed to assist or supplement the development,
understanding or application of the Products.

Improvement means any existing or future development, enhancement or modification of any
of the Products, Patents or the Documentation created or contributed to by the Inventors.

Intellectual Property Rights means copyright, know-how, patents, patent applications,
designs, eligible circuit layouts and all other intellectual property as defined in
Article 2 of the Convention establishing the World Intellectual Property Organisation of
July 1967 and any rights in or to any inventions.

Moral Rights means any of the rights described in Article 6bis of the Berne Convention
for Protection of Literary and Artistic Works 1886 (as amended and revised from time to
time), being ‘droit moral’ or other analogous rights arising under any statute (including
the Copyright Act 1968 (Cth)).

Patents means the patents and patent applications specified in the Schedule and, where
reference is made to a PCT application, includes all national patents or patent
applications anywhere in the world that are derived or arise from that PCT application.

Products means any and all of the extensive portfolio of custom-designed clinical and
prefilled safety syringe products of Unilife and Unitract.

Services means all past and future assistance and services provided by the Inventors to
Unilife and Unitract in relation to the development of the Products (including all
Improvements).

Shares means 2,500,000 fully paid, ordinary shares in Unilife to be issued to each
Inventor in accordance with this Deed.

	9.2	 	In the interpretation of this Deed, the following provisions apply unless the context
otherwise requires:

	 	9.2.1	 	headings are inserted for convenience only and do not affect the
interpretation of this Deed;

	 	9.2.2	 	a reference to a clause, part, schedule or attachment is a reference to
a clause, part, schedule or attachment of or to this Deed;

	 	9.2.3	 	an expression importing a natural person includes any company, trust,
partnership, joint venture, association, body corporate or governmental agency;

	 	9.2.4	 	a word which denotes the singular denotes the plural, a word which
denotes the plural denotes the singular, and a reference to any gender denotes the
other genders; and

	 	9.2.5	 	where a word or phrase is given a particular meaning, other parts of
speech and grammatical forms of that word or phrase have corresponding meanings.

 

6

 

	 	 	 	 	 	 	 
	Execution and date
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Executed as a deed.
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Executed by Unilife Medical Solutions
Limited ACN 008 071 403
acting by the following persons or,
if the seal is affixed,
witnessed by the following persons:

	 
	 	 	 	 	 	 
	 

Signature of director

	 	 	 	 

Signature of director/company secretary
	 	 
	 
	 	 	 	 	 	 
	 

Name of director (print)

	 	 	 	 

Name of director/company secretary (print)
	 	 
	 
	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Executed by Unitract Syringe
Pty Ltd ACN 101 059 723 acting
by the following persons or,
if the seal is affixed, witnessed
by the following persons:

	 
	 	 	 	 	 	 
	 

Signature of director

	 	 	 	 

Signature of director/company secretary
	 	 
	 
	 	 	 	 	 	 
	 

Name of director (print)

	 	 	 	 

Name of director/company secretary (print)
	 	 
	 
	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Signed, sealed and delivered by
Craig Stephen Thorley in the
presence of:

	 
	 	 	 	 	 	 
	

	 

Signature of witness

	 	 	 	/s/ Craig Stephen Thorley 

Signature of Craig Stephen Thorley
	 	 
	 
	 	 	 	 	 	 
	 

Name of witness (print)

	 	 	 	 	 	 
	

	 
	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 

 

7

 

	 	 	 	 	 	 	 
	Signed, sealed and delivered
by Joseph Hermes Kaal in the
presence of:

	 
	 	 	 	 	 	 
	

	 

Signature of witness

	 	 	 	/s/ Joseph Hermes Kaal 

Signature of Joseph Hermes Kaal
	 	 
	 
	 	 	 	 	 	 
	 

Name of witness (print)

	 	 	 	 	 	 
	

	 
	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 

 

8

 

Schedule

The Patents

Improved Controlled Retraction Syringe and Plunger, WO2006/119570 (Published 16 November 2006),
Application Number PCT/AU2006/000618

Controlled Retraction Syringe and Plunger, WO2006/108243 (Published 19 October 2006), Application
Number PCT/AU2006/000516

Syringe Needle Sheath, WO2006/007642 (Published 26 January 2006), Application Number
PCT/AU2005/001054

Retractable Syringe With Plunger Disabling System, WO2005/072801 (Published 11 August 2005),
Application Number PCT/AU2005/000106

One Use Syringe With Rachet On Plunger And Pawl On Body, WO2005/072797 (Published 11 August 2005),
Application Number PCT/AU 2004/000354

Syringe Spring Retainer, WO2004/082747 (Published 30 September 2004), Application Number
PCT/AU2004/000354

Single Use Syringe, WO2001/080930 (Published 1 November 2001), Application Number PCT/AU2001/000458

Retractable Syringe, Australian patent 731159 and US patent 6083199 both filed 22 September 1998

Prefilled Retractable Syringe, Plunger And Needle Assembly, WO2009/003234 (Published 8 January
2009), Application Number PCT/AU2008/000971 and Taiwan patent application 97124808 (filed 1 July
2008) and Thailand patent application 0801003413 (filed 2 July 2008)

 

9Exhibit 10.36

Exhibit 10.36

Restricted Stock Agreement

under the

Unilife Corporation

2009 Stock Incentive Plan

Grantee:  Alan D. Shortall

No. of Shares: 1,166,000

This Agreement (the “Agreement”) evidences the award of 1,166,000 restricted shares (each, an
“Award Share,” and collectively, the “Award Shares”) of the common stock of Unilife Corporation, a
Delaware corporation (the “Company”), granted to you, Alan D. Shortall, effective as of
 _____ 
(the “Grant Date”), pursuant to the Unilife Corporation 2009 Stock Incentive Plan (the
“Plan”) and conditioned upon your agreement to the terms described below. All of the provisions of
the Plan are expressly incorporated into this Agreement.

1. Terminology. Unless otherwise provided in this Agreement, capitalized words used
herein are defined in the Glossary at the end of this Agreement.

2. Vesting.

(a) All of the Award Shares are nonvested and forfeitable as of the Grant Date.

(b) The table below sets forth the performance milestones (each, a “Performance Milestone”)
that apply to the Award Shares. The number of shares set forth opposite each Performance Milestone
in the table shall become vested and nonforfeitable upon the successful achievement of that
Performance Milestone, as determined by the Administrator, provided that (i) such achievement
occurs on or before the fifth anniversary of the Grant Date and (ii) either your Service
with the Company is continuous from the Grant Date through the applicable date upon which such
achievement occurs or your Service with the Company was terminated by the Company without Cause
prior to the achievement of the Performance Milestone. The Performance Milestones, and the number
of Award Shares eligible to vest upon the achievement of those milestones, are as follows:

	 	 	 
	 	 	Number of Award Shares
	PERFORMANCE MILESTONES	 	Eligible to Vest
	Signing supply agreements with sanofi-aventis for
100 million or more Unifill Ready to Fill Syringes.
	 	233,200 Shares
	First new agreement for Unifill Ready to Fill
Syringe with pharmaceutical company other than
sanofi-aventis or its affiliates.
	 	233,200 Shares
	Agreement with any pharmaceutical company,
including sanofi-aventis, for a new product (other
than the Unifill Ready to Fill Syringe).
	 	233,200 Shares
	Expand business capability by installing the first
Unifill Ready to Fill Syringe production line in a
clean room in Unilife’s new Pennsylvania facility,
including the successful operation qualification
(OQ) of the line.
	 	233,200 Shares
	First shipment of production quality (PQ), sterile
Unifill Ready to Fill Syringes to sanofi-aventis
from commercial production line.
	 	233,200 Shares
	 	 	 
	Total
	 	1,166,000 Shares
	 	 	 

(c) All of the Award Shares, to the extent not earlier forfeited, will become vested and
nonforfeitable immediately before and contingent upon the occurrence of a Change in Control
(notwithstanding whether your Service continues after the Change in Control), upon your death, or
upon your ceasing to be employed by the Company by reason of Disability.

 

 

 

(d) All of the Award Shares that have not become vested and nonforfeitable on or before the
fifth anniversary of the Grant Date will be immediately forfeited by you at the close of business
(of the principal executive offices of the Company) on the fifth anniversary of the Grant Date and
transferred to the Company upon such forfeiture for no consideration. Any accrued dividends
attributable to such forfeited Award Shares shall also be forfeited if and when the Award Shares
are forfeited.

3. Termination of Employment or Service.

(a) If your Service with the Company ceases for any reason other than your death, Disability,
or a termination by the Company without Cause, all Award Shares that are not then vested and
nonforfeitable will be immediately forfeited by you and transferred to the Company upon such
cessation for no consideration. Any accrued dividends attributable to such forfeited Award Shares
shall also be forfeited if and when the Award Shares are forfeited.

(b) You acknowledge and agree that upon the forfeiture of any unvested Award Shares in
accordance with Section 2(d) or Section 3(a), (i) your right to vote and to receive cash dividends
on, and all other rights, title or interest in, to or with respect to, the forfeited Award Shares
shall automatically, without further act, terminate and (ii) the forfeited Award Shares shall be
returned to the Company. You hereby irrevocably appoint (which appointment is coupled with an
interest) the Company as your agent and attorney-in-fact to take any necessary or appropriate
action to cause the forfeited Award Shares to be returned to the Company, including without
limitation executing and delivering stock powers and instruments of transfer, making endorsements
and/or making, initiating or issuing instructions or entitlement orders, all in your name and on
your behalf. You hereby ratify and approve all acts done by the Company as such attorney-in-fact.
Without limiting the foregoing, you expressly acknowledge and agree that any transfer agent for the
Common Stock of the Company is fully authorized and protected in relying on, and shall incur no
liability in acting on, any documents, instruments, endorsements, instructions, orders or
communications from the Company in connection with the forfeited Award Shares or the transfer
thereof, and that any such transfer agent is a third party beneficiary of this Agreement.

4. Restrictions on Transfer.

(a) Before an Award Share becomes vested and nonforfeitable, it may not be sold, assigned,
transferred, pledged, hypothecated or disposed of in any way (whether by operation of law or
otherwise), except by will or the laws of descent and distribution, and shall not be subject to
execution, attachment or similar process.

(b) Unless determined otherwise by the Administrator, for the period that commences upon the
date that an Award Share becomes vested and nonforfeitable and ends on the one-year anniversary of
that date (the “Holding Period”), the vested Award Share may not be sold, assigned, transferred,
pledged, hypothecated or disposed of in any way (whether by operation of law or otherwise), except
by will or the laws of descent and distribution, and shall not be subject to execution, attachment
or similar process, and you may not enter into a put, call or other transaction to hedge the risk
of holding such Award Share; provided, however, that the Holding Period shall expire on the date on
which a Change in Control occurs and on the date on which your Service with the Company terminates
for any reason. The provisions of this Section 4(b) shall not apply to any Award Share that, in
order to satisfy tax withholding obligations that arise in connection with the vesting of the Award
Shares granted under this Agreement, is surrendered to the Company or is sold in the open market
and the sale proceeds are delivered to the Company.

(c) The Company shall be entitled to place a stop transfer order on the Award Shares until the
Holding Period described in Section 4(b) expires. Any attempt to sell, transfer, pledge, assign or
otherwise alienate or hypothecate any such Award Shares in contravention of the restrictions set
forth in Section 4(a) or Section 4(b) shall be null and void and without effect. The Company shall
not be required to (i) transfer on its books any Award Shares that have been sold or transferred in
contravention of this Agreement or (ii) treat as the owner of Award Shares, or otherwise accord
voting, dividend or liquidation rights to, any transferee to whom Award Shares have been
transferred in contravention of this Agreement.

 

- 2 -

 

5. Stock Certificates. You are reflected as the owner of record of the Award Shares
as of the Grant Date on the Company’s books. The Company or an escrow agent appointed by the
Administrator will hold in escrow the share certificates for safekeeping, or the Company may
otherwise retain the Award Shares in uncertificated book entry form, until the Award Shares become
vested and nonforfeitable and freely transferable. Until the Award Shares become vested and
nonforfeitable and the relevant Holding Period has expired, any share certificates representing
such shares will include a legend to the effect that you may not sell, assign, transfer, pledge, or
hypothecate the Award Shares. Any cash dividends that become payable with respect to an unvested
Award Share will be accrued and held by the Company or an escrow agent appointed by the
Administrator until the Award Share becomes vested and will be paid to you within fifteen days
after the date on which the related Award Share becomes vested. As soon as practicable after
vesting of an Award Share and expiration of the relevant Holding Period, the Company will continue
to retain the Award Share in uncertificated book entry form but remove the Holding Period
restrictions on transfer on its books with respect to that Award Share. Alternatively, upon your
request, the Company will deliver a share certificate to you or deliver a share electronically or
in certificate form to your designated broker on your behalf, for the vested Award Share.

6. Tax Withholding, Tax Election, and Excise Tax Adjustments.

(a) You hereby agree to make adequate provision for foreign, federal, state and local taxes,
including any social tax obligation, required by law to be withheld, if any, which arise in
connection with the grant or vesting of the Award Shares. The Company agrees that it will, upon
your request, permit you to satisfy, in whole or in part, any withholding tax obligation, including
any social tax obligation, which may arise in connection with the grant or vesting of the Award
Shares either by electing to have the Company withhold the issuance of, or redeem, Award Shares
(other than unvested Award Shares) or by electing to deliver to the Company already-owned, fully
vested shares of Common Stock of the Company, in either case having a Fair Market Value equal to
the amount necessary to satisfy the statutory minimum withholding amount due. If you do not submit
your request pursuant to the immediately preceding sentence on or before the date upon which the
withholding obligation arises, the Company shall have the right to deduct from any compensation or
any other payment of any kind due you (including withholding the issuance or delivery of shares of
Common Stock or redeeming Award Shares) the amount of any federal, state, local or foreign taxes,
including any social tax obligation, required by law to be withheld as a result of the grant or
vesting of the Award Shares in whole or in part; provided, however, that the value of the shares of
Common Stock withheld or redeemed may not exceed the statutory minimum withholding amount required
by law. In lieu of such deduction, the Company may require you to make a cash payment to the
Company equal to the amount required to be withheld. If you do not make provision for the payment
of such taxes when requested, the Company may refuse to issue any Common Stock certificate under
this Agreement or may refuse to remove transfer restrictions on any Award Share until arrangements
satisfactory to the Committee have been made.

(b) You hereby acknowledge that you have been advised by the Company to seek independent tax
advice from your own advisors regarding the availability and advisability of making an election
under Section 83(b) of the Code, and that any such election, if made, must be made within 30 days
of the Grant Date. You expressly acknowledge that you are solely responsible for filing any such
Section 83(b) election with the appropriate governmental authorities, irrespective of the fact that
such election is also delivered to the Company. You may not rely on the Company or any of its
officers, directors or employees for tax or legal advice regarding this award. You acknowledge
that you have sought tax and legal advice from your own advisors regarding this award or have
voluntarily and knowingly foregone such consultation.

 

- 3 -

 

(c) Excise Tax Adjustments.

(i) Notwithstanding any other provision herein or any provision in an employment, severance,
change in control or similar agreement to the contrary, in the event it shall be determined that
any payment in the nature of compensation by the Company to you or for your benefit, whether paid,
payable, distributed or distributable pursuant to this Agreement or otherwise (including, without
limitation, any severance payment or accelerated vesting of stock options or restricted stock
granted by the Company) (each, a “Payment” and collectively, the “Total Payments”) would be
subject to the excise tax imposed by Section 4999 of the Code (or any successor provision) or any
interest or penalties with respect to such excise tax (such excise tax, together with any such
interest and penalties, are collectively referred to in this Agreement as the “Excise Tax”), then
the Total Payments shall be reduced (the “Reduction”) to the minimum extent necessary (but not
below zero) so that no portion thereof shall be subject to the Excise Tax; provided,
however, that such Reduction shall be made only if, by reason of such Reduction, the net
after-tax benefit received by you (or for your benefit) shall exceed the net after-tax benefit that
would be received by you (or for your benefit) if no such Reduction was made and you bore the
Excise Tax payment liability.

(ii) If a Reduction is required pursuant to the terms of Section 6(c)(i), the Total Payments
shall be reduced in the following order: any Payments constituting cash severance shall be reduced
first, any other Payments in the nature of cash compensation shall be reduced second, the number or
accelerated vesting of outstanding equity awards other than stock options shall be reduced third,
and lastly, the number or accelerated vesting of outstanding stock options shall be reduced.

(iii) If it shall be determined that any Payment would be subject to the Excise Tax and
applying the Reduction would not result in a greater net after-tax benefit to you than if no such
Reduction was made and you bore the Excise Tax payment liability, then you shall be entitled to
receive from the Company an additional payment (a “Gross-Up Payment”) in an amount such that after
the payment by you of all taxes (including any interest or penalties imposed with respect to such
taxes), including any Excise Tax, imposed upon the Gross-Up Payment, you retain an amount of the
Gross-Up Payment equal to the Excise Tax imposed upon the Total Payments. In all events, the
Gross-Up Payment, if any, shall be made by no later than the December 31st following the calendar
year in which you remit the Excise Tax.

(iv) All determinations required under this Section 6(c), including without limitation whether
a Reduction shall be applied, the amount of such Reduction, and/or the amount of any Gross-Up
Payment, shall be made by a nationally recognized accounting firm selected by the Company and
reasonably acceptable to you (which may be, but will not be required to be, the Company’s
independent auditors) and such determinations shall be binding on the Company and you.

7. Adjustments for Corporate Transactions and Other Events.

(a) Stock Dividend, Stock Split and Reverse Stock Split. Upon a stock dividend of, or
stock split or reverse stock split affecting, the Common Stock, the number of Award Shares and the
number of such Award Shares that are nonvested and forfeitable shall, without further action of the
Administrator, be adjusted to reflect such event. The Administrator shall make adjustments, in its
discretion, to address the treatment of fractional shares with respect to the Award Shares as a
result of the stock dividend, stock split or reverse stock split; provided that such adjustments do
not result in the issuance of fractional Award Shares. Adjustments under this Section 7 will be
made by the Administrator, whose determination as to what adjustments, if any, will be made and the
extent thereof will be final, binding and conclusive.

(b) Binding Nature of Agreement. The terms and conditions of this Agreement shall
apply with equal force to any additional and/or substitute securities received by you in exchange
for, or by virtue of your ownership of, the Award Shares, to the same extent as the Award Shares
with respect to which such additional and/or substitute securities are distributed, whether as a
result of any spin-off, stock split-up, stock dividend, stock distribution, other reclassification
of the Common Stock of the Company, or similar event, except as otherwise determined by the
Administrator. If the Award Shares are converted into or exchanged for, or stockholders of the
Company receive by reason of any distribution in total or partial liquidation or pursuant to any
merger of the Company or acquisition of its assets, securities of another entity, or other property
(including cash), then the rights of the Company under this Agreement shall inure to the benefit of
the Company’s successor, and this Agreement shall apply to the securities or other property
(including cash) received upon such conversion, exchange or distribution in the same manner and to
the same extent as the Award Shares.

 

- 4 -

 

8. Non-Guarantee of Employment or Service Relationship. Nothing in the Plan or this
Agreement shall alter your employment status or other service relationship with the Company, nor be
construed as a contract of employment or service relationship between the Company and you, or as a
contractual right of you to continue in the employ of, or in a service relationship with, the
Company for any period of time, or as a limitation of the right of the Company to discharge you at
any time with or without cause or notice and whether or not such discharge results in the
forfeiture of any Award Shares or any other adverse effect on your interests under the Plan or this
Agreement.

9. Rights as Stockholder. Except as otherwise provided in this Agreement with respect
to the nonvested and forfeitable Award Shares and the payment of dividends thereon, you will
possess all incidents of ownership of the Award Shares, including the right to vote the Award
Shares and receive dividends and/or other distributions declared on the Award Shares.

10. The Company’s Rights. The existence of the Award Shares shall not affect in any
way the right or power of the Company or its stockholders to make or authorize any or all
adjustments, recapitalizations, reorganizations or other changes in the Company’s capital structure
or its business, or any merger or consolidation of the Company, or any issue of bonds, debentures,
preferred or other stocks with preference ahead of or convertible into, or otherwise affecting the
Common Stock or the rights thereof, or the dissolution or liquidation of the Company, or any sale
or transfer of all or any part of the Company’s assets or business, or any other corporate act or
proceeding, whether of a similar character or otherwise.

11. Notices. All notices and other communications made or given pursuant to this
Agreement shall be in writing and shall be sufficiently made or given if hand delivered or mailed
by certified mail, addressed to you at the address contained in the records of the Company, or
addressed to the Administrator, care of the Company for the attention of its Corporate Secretary at
its principal executive office or, if the receiving party consents in advance, transmitted and
received via telecopy or via such other electronic transmission mechanism as may be available to
the parties.

12. Entire Agreement. This Agreement contains the entire agreement between the
parties with respect to the Award Shares granted hereunder. Any oral or written agreements,
representations, warranties, written inducements, or other communications made prior to the
execution of this Agreement with respect to the Award Shares granted hereunder shall be void and
ineffective for all purposes.

13. Amendment. This Agreement may be amended from time to time by the Administrator
in its discretion; provided, however, that this Agreement may not be modified in a
manner that would have a materially adverse effect on your rights under this Agreement as
determined in the discretion of the Administrator, except as provided in the Plan or in a written
document signed by each of the parties hereto.

14. Conformity with Plan. This Agreement is intended to conform in all respects with,
and is subject to all applicable provisions of, the Plan. Inconsistencies between this Agreement
and the Plan shall be resolved in accordance with the terms of the Plan. In the event of any
ambiguity in this Agreement or any matters as to which this Agreement is silent, the Plan shall
govern. A copy of the Plan is available upon request to the Administrator.

15. Governing Law. The validity, construction and effect of this Agreement, and of
any determinations or decisions made by the Administrator relating to this Agreement, and the
rights of any and all persons having or claiming to have any interest under this Agreement, shall
be determined exclusively in accordance with the laws of the State of Delaware, without regard to
its provisions concerning the applicability of laws of other jurisdictions. Any suit with respect
hereto will be brought in the federal or state courts in the districts which include the city and
state in which the principal executive offices of the Company are located on the date on which the
suit arises, and you hereby agree and submit to the personal jurisdiction and venue thereof.

 

- 5 -

 

16. Headings. The headings in this Agreement are for reference purposes only and
shall not affect the meaning or interpretation of this Agreement.

17. Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument.

18. Electronic Delivery of Documents. By your signing this Agreement, you (i) consent
to the electronic delivery of this Agreement, all information with respect to the Plan and the
Award Shares and any reports of the Company provided generally to the Company’s stockholders; (ii)
acknowledge that you may receive from the Company a paper copy of any documents delivered
electronically at no cost to you by contacting the Company by telephone or in writing; (iii)
further acknowledge that you may revoke your consent to the electronic delivery of documents at any
time by notifying the Company of such revoked consent by telephone, postal service or electronic
mail; and (iv) further acknowledge that you understand that you are not required to consent to
electronic delivery of documents.

19. No Future Entitlement. By your signing this Agreement, you acknowledge and agree
that: (i) the grant of these Award Shares is a one-time benefit which does not create any
contractual or other right to receive future grants of stock, or compensation in lieu of stock
grants, even if stock grants have been granted repeatedly in the past; (ii) all determinations with
respect to any such future grants, including, but not limited to, the times when stock grants shall
be granted, the maximum number of shares subject to each stock grant, and the times or conditions
under which restrictions on such stock grants shall lapse, will be at the sole discretion of the
Administrator; (iii) the value of this stock grant is an extraordinary item of compensation which
is outside the scope of your employment contract, if any; (iv) the value of this stock grant is not
part of normal or expected compensation or salary for any purpose, including, but not limited to,
calculating any termination, severance, resignation, redundancy, end of service payments or similar
payments, or bonuses, long-service awards, pension or retirement benefits; (v) the vesting of these
Award Shares ceases upon termination of employment with the Company or transfer of employment from
the Company, or other cessation of eligibility for any reason, except as may otherwise be
explicitly provided in this Agreement; (vi) the Company does not guarantee any future value of
these Award Shares; and (vii) no claim or entitlement to compensation or damages arises if these
Award Shares do not increase in value and you irrevocably release the Company from any such claim
that does arise.

20. Personal Data. For the exclusive purpose of implementing, administering and
managing this stock grant, you, by signing this Agreement, consent to the collection, receipt, use,
retention and transfer, in electronic or other form, of your personal data by and among the Company
and its third party vendors. You understand that personal data (including but not limited to,
name, home address, telephone number, employee number, employment status, social security number,
tax identification number, date of birth, nationality, job and payroll location, data for tax
withholding purposes and shares awarded, cancelled, exercised, vested and unvested) may be
transferred to third parties assisting in the implementation, administration and management of this
stock grant and the Plan and you expressly authorize such transfer as well as the retention, use,
and the subsequent transfer of the data by the recipient(s). You understand that these recipients
may be located in your country or elsewhere, and that the recipient’s country may have different
data privacy laws and protections than your country. You understand that data will be held only as
long as is necessary to implement, administer and manage this stock grant. You understand that you
may, at any time, request a list with the names and addresses of any potential recipients of the
personal data, view data, request additional information about the storage and processing of data,
require any necessary amendments to data or refuse or withdraw the consents herein, in any case
without cost, by contacting in writing the Company’s Secretary. You understand, however, that
refusing or withdrawing your consent may affect your ability to accept a stock grant.

{Glossary begins on next page}

 

- 6 -

 

GLOSSARY

(a) “Administrator” means the Board of Directors of Unilife Corporation or such committee or
committees appointed by the Board to administer the Plan.

(b) “Affiliate” means any entity, whether now or hereafter existing, which controls, is
controlled by, or is under common control with, Unilife Corporation (including, but not limited to,
joint ventures, limited liability companies, and partnerships). For this purpose, “control” shall
mean ownership of 50% or more of the total combined voting power or value of all classes of stock
or interests of the entity, or the power to direct the management and policies of the entity, by
contract or otherwise.

(c) “Cause” means the occurrence of an event that allows the Company to terminate your
employment without notice as specified in section 15.3 of the Executive Employment Agreement, dated
October 26, 2008, between you and Unilife Medical Solutions Limited or, if there is a successor
employment agreement between you and the Company in effect immediately before your termination of
Service, then “Cause” shall have the meaning ascribed to such term or words of similar import in
such successor employment agreement.

(d) “Change in Control” has the meaning ascribed thereto in the Plan.

(e) “Code” means the Internal Revenue Code of 1986, as amended.

(f) “Company” means Unilife Corporation and its Affiliates, except where the context otherwise
requires. For purposes of determining whether a Change in Control has occurred, Company shall mean
only Unilife Corporation.

(g) “Disability” means any medically determinable physical or mental impairment that is
expected to be permanent in nature and which renders you, in the good faith judgment of the
Administrator, unable to perform the essential duties of your position.

(h) “Holding Period” means the period described in Section 4(b) of this Agreement as it is
measured from the vesting date of each Award Share.

(i) “Performance Milestone” shall have the meaning set forth in Section 2(b) of this
Agreement.

(j) “Service” means your employment with the Company and its Affiliates. Your Service with
the Company and its Affiliates will be considered to have ceased if, immediately after a sale,
merger or other corporate transaction, the trade, business or entity with which you are employed or
otherwise have a service relationship is not Unilife Corporation or its successor, or an Affiliate
of Unilife Corporation or its successor.

(k) “You”; “Your”. You means the recipient of the Award Shares as reflected in the first
paragraph of this Agreement. Whenever the word “you” or “your” is used in any provision of this
Agreement under circumstances where the provision should logically be construed, as determined by
the Administrator, to apply to the estate, personal representative, or beneficiary to whom the
Award Shares may be transferred by will or by the laws of descent and distribution, the words “you”
and “your” shall be deemed to include such person.

{Signature page follows}

 

- 7 -

 

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer.

	 	 	 	 	 	 	 
	 	 	UNILIFE CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Date:	 	 	 	 
	 

	 	 	 	 

	 	 

The undersigned hereby acknowledges that he/she has carefully read this Agreement and agrees to be
bound by all of the provisions set forth herein. The undersigned also consents to electronic
delivery of all notices or other information with respect to the Award Shares or the Company.

	 	 	 	 	 	 	 
	WITNESS:	 	GRANTEE	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Date:	 	 	 	 
	 

	 	 	 	 

	 	 

Enclosure: Prospectus for the Unilife Corporation 2009 Stock Incentive Plan

 

- 8 -

 

IMPORTANT FEDERAL TAX INFORMATION

INSTRUCTIONS REGARDING SECTION 83(b) ELECTIONS

	1.	 	The 83(b) Election is irrevocable. The 83(b) Election is a voluntary election that
is available to you. It is your decision whether to file an 83(b) Election.

	2.	 	If you choose to make an 83(b) Election, the 83(b) Election Form must be filed with the
Internal Revenue Service within 30 days of the Grant Date; no exceptions to this deadline are
made. You should send the election to the internal revenue service center located at the
address to which you send your federal income tax return (IRS form 1040) based on your place
of residence. The election should be sent via certified mail with return receipt
requested or a delivery service that provides proof of delivery.

	3.	 	You must deliver a copy of the 83(b) Election Form to the Corporate Secretary or other
designated officer of the Company as soon as practicable after you receive proof that the
original was received by the Internal Revenue Service. Irrespective of the fact that a copy
of your 83(b) Election Form is to be delivered to the Company, you remain solely responsible
for properly filing the original with the Internal Revenue Service.

	4.	 	In addition to making the filing under Item 2 above, you must attach a copy of your 83(b)
Election Form to your federal tax return for the taxable year that includes the Grant Date.
Applicable state law also may require you to attach a copy of the 83(b) Election Form to any
state income tax returns that you file for that taxable year.

	5.	 	If you make an 83(b) Election and later forfeit the Award Shares, you will not be entitled to
a refund of the taxes paid with respect to the gross income you recognized under the 83(b)
Election.

	6.	 	You must consult your personal tax advisor before making an 83(b) Election. You may
not rely on this information, the Company, or any of the Company’s officers, directors, or
employees for tax or legal advice regarding the Award Shares or the 83(b) Election. The
election form attached to these instructions is intended as a sample only. It must be
tailored to your circumstances and may not be relied upon without consultation with a personal
tax advisor.

 

 

SECTION 83(b) ELECTION FORM

Election Pursuant to Section 83(b) of the Internal Revenue Code to

Include Property in Gross Income in Year of Transfer

The undersigned hereby makes an election pursuant to Section 83(b) of the Internal Revenue
Code with respect to the property described below and supplies the following information in
accordance with the regulations promulgated thereunder:

1. The name, address, and taxpayer identification number of the undersigned are:

           
                     
                     
                     
      

           
                     
                     
                     
      

           
                     
                     
                     
      

_____ 
-_-
 _____ 

2. The property with respect to which the election is made is
 _____ 
shares of
Common Stock, par value $0.01 per share, of Unilife Corporation, a Delaware corporation (the
“Company”).

3. The date on which the property was transferred was
 _____, the date on which the
taxpayer received the property pursuant to a grant of restricted stock.

4. The taxable year to which this election relates is calendar year 20__.

5. The property is subject to restrictions in that the property is not transferable and is
subject to a substantial risk of forfeiture until the taxpayer vests in the property. The taxpayer
will vest in the property provided that certain performance milestones set forth in the agreement
under which the property was transferred to the taxpayer are satisfied before the fifth anniversary
of the transfer date and provided that the taxpayer remains employed with the Company through the
date on which the performance milestone is achieved or the taxpayer’s employment is earlier
terminated by the Company without cause.

6. The fair market value at the time of transfer (determined without regard to any
restrictions other than restrictions which by their terms will never lapse) of the property with
respect to which this election is being made is $_____  per share; with a cumulative fair
market value of $_____.

7. The taxpayer did not pay any amount for the property transferred.

 

 

 

8. A copy of this statement was furnished to the Corporate Secretary or other designated
officer of the Company. The taxpayer rendered services to Unilife Medical Solutions Limited and
Unilife Corporation in connection with the transfer of the property with respect to which this
election is being made.

9. This election is made to the same effect, and with the same limitations, for purposes of
any applicable state statute corresponding to Section 83(b) of the Internal Revenue Code.

The undersigned understands that the foregoing election may not be revoked except with the
consent of the Commissioner of Internal Revenue.

	 	 	 	 	 
	Signed:
	 	 	 	 
	 

	 	 

	 	 
	Date:

	 	                                                            	 	 

 

 

 

Letter for filing §83(b) Election Form

[Date]

CERTIFIED MAIL

RETURN RECEIPT REQUESTED

***Please insert the IRS Service Center where you file your federal income tax return below.***

Internal Revenue Service Center

                                                                    
            

                                                                  
              

                                                                   
             

	 	 	 	 	 
	 

	 	Re:
	 	83(b) Election of Alan D. Shortall

Social Security Number:                                                             

Dear Sir/Madam:

Enclosed is an election under §83(b) of the Internal Revenue Code of 1986, as amended, with
respect to certain shares of stock of Unilife Corporation that were transferred to me on

 _____, 20__.

Please file this election.

	 	 	 	 	 
	 

	 	Sincerely,	 	 
	 
	 	 	 	 
	 

	 	 

Alan D. Shortall
	 	 

cc: Corporate Secretary of Unilife Corporation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]